Stay updated on Tiragolumab Combo in Stage II Melanoma Clinical Trial
Sign up to get notified when there's something new on the Tiragolumab Combo in Stage II Melanoma Clinical Trial page.

Latest updates to the Tiragolumab Combo in Stage II Melanoma Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov footer revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA new revision entry (v3.7.0) was added to the record history, and the older revision (v3.6.6) was removed from the list. This updates the visible history to reflect the latest versioning of the study record.SummaryDifference0.1%

- Check43 days agoChange DetectedThe history now shows a new revision entry v3.6.6 and removes the previous revision v3.6.5, indicating an administrative update to the record.SummaryDifference0.1%

- Check64 days agoChange DetectedThe study record history now shows a new revision entry v3.6.5, replacing the previous v3.6.4 and updating the revision trail for the record.SummaryDifference0.1%

- Check79 days agoChange DetectedA new revision entry for v3.6.4 has been added to the study's record history. The previous revision, v3.6.3, has been removed from the current listing.SummaryDifference0.1%

- Check100 days agoChange DetectedA new revision entry, v3.6.3, was added to the record history. The previous revision, v3.6.2, was removed from the history list.SummaryDifference0.1%

Stay in the know with updates to Tiragolumab Combo in Stage II Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tiragolumab Combo in Stage II Melanoma Clinical Trial page.